期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Functional verification of the diphtheria toxin A gene in a recombinant system
1
作者 Jingfeng Zhang Hengxi Wei +4 位作者 Xinzheng Guo Minghua Hu Fenglei Gao Li Li Shouquan Zhang 《Journal of Animal Science and Biotechnology》 SCIE CAS 2013年第1期34-40,共7页
Diphtheria toxin A (DTA), a segment of the diphtheria toxin (tox), inhibits protein synthesis in cells. When released from a cell, DTA is nontoxic and cannot enter other cells independently without the help of dip... Diphtheria toxin A (DTA), a segment of the diphtheria toxin (tox), inhibits protein synthesis in cells. When released from a cell, DTA is nontoxic and cannot enter other cells independently without the help of diphtheria toxin B. In this study, we artificially synthesized the DTA gene sequence and cloned it into pEGFP-N1 to generate the recombinant vector pEGFP-N1-DTA. This recombinant vector was then transfected into 293T cells to observe the effect of DTA protein expression on enhanced green fluorescent protein (EGFP) protein expression and the proliferation of 293T cells. After 48 h, high levels of EGFP expression were seen in control pEGFP-Nl-transfected cells, whereas very low levels were seen in cells transfected with pEGFP-N1-DTA. Reverse transcription polymerase chain reaction confirmed the expression of the DTA gene in cells transfected with pEGFP-N^-DTA. Further, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (M-I-I-) assay revealed a significant difference in cell proliferation between the control group and the pEGFP-N1-DTA-transfected group. Using the expression of EGFP expression as an indicator, this study revealed that DTA expression can inhibit intracellular protein synthesis and cell proliferation. 展开更多
关键词 diptheria toxin A Cell proliferation Protein synthesis
下载PDF
两种百白破联合疫苗基础免疫后百日咳凝集抗体和白喉抗体监测分析 被引量:3
2
作者 朱建琼 王莹 《中国计划免疫》 2004年第2期84-86,共3页
为了解无细胞百白破联合疫苗 (DTaP)和全细胞百白破联合疫苗 (DTwP)接种后的血清学免疫效果 ,在东莞市随机选取 3月龄健康婴儿 10 7名 ,分两组分别用DTaP和DTwP做基础免疫 ,在免疫前和免疫后 1个月分别采血 ,用微量凝集试验检测百日咳... 为了解无细胞百白破联合疫苗 (DTaP)和全细胞百白破联合疫苗 (DTwP)接种后的血清学免疫效果 ,在东莞市随机选取 3月龄健康婴儿 10 7名 ,分两组分别用DTaP和DTwP做基础免疫 ,在免疫前和免疫后 1个月分别采血 ,用微量凝集试验检测百日咳凝集抗体 ,采用间接血球凝集试验检测白喉抗体。结果表明 :经DTaP基础免疫后 ,百日咳凝集抗体保护率为 95 83% ,≥ 4倍增长率为 10 0 0 0 % ,几何平均滴度 (GMT)为 1∶783 4 3;白喉抗体的保护率为 10 0 0 0 % ,≥ 4倍增长率为 10 0 0 0 % ,平均白喉抗毒素含量 (DAT)为 0 6 8IU/ml。经DTwP基础免疫后百日咳凝集抗体保护率为 98 0 4 % ,≥ 4倍增长率为 10 0 0 0 % ,GMT为 1∶16 34 93;白喉抗体保护率为 10 0 0 0 % ,≥ 4倍增长率为 10 0 0 0 % ,DAT为 1 2 8IU/ml。DTaP和DTwP两组免疫前各项指标差异均无显著的统计学意义 ,但免疫后两组的百日咳凝集抗体GMT的差异有非常显著的统计学意义 (t =4 6 8,P <0 0 1)。采用DTaP和DTwP作基础免疫均可获得良好的百日咳和白喉的血清学免疫效果。 展开更多
关键词 百白破联合疫苗 基础免疫 百日咳凝集抗体 监测 儿童 白喉抗毒素
原文传递
Randomized controlled trial of topical EMLA and vapocoolant spray for reducing pain during wDPT vaccination 被引量:1
3
作者 Navratan Kumar Gupta Amit Upadhyay +3 位作者 Ajeet Kumar Dwivedi Astha Agarwal Vijay Jaiswal Abhishek Singh 《World Journal of Pediatrics》 SCIE CAS CSCD 2017年第3期236-241,共6页
Background:Intramuscular vaccination is among the most common source of iatrogenic pain in infants.Vapocoolant sprays are rapid-acting alternative to topical anesthetics.They provide transient anesthesia via evaporati... Background:Intramuscular vaccination is among the most common source of iatrogenic pain in infants.Vapocoolant sprays are rapid-acting alternative to topical anesthetics.They provide transient anesthesia via evaporation induced skin cooling,and reduce pain due to vaccine injection in children and adults.The objective was to compare the synergistic analgesic effect of eutectic mixture of local anesthetics (EMLA) with breastfeeding (EB group) and vapocoolant spay with breastfeeding (VB group) to that of only breastfeeding (BO group) during whole cell diptheria,pertussis and tetanus (wDPT) vaccination.Methods:A double blind randomized controlled trial was done to include infants up to 3 months of age who came for their first wDPT vaccination.The primary outcome variable was the duration of cry after vaccination.Secondary outcome variables were Modified Facial Coding Score,Neonatal Infant Pain Scale and latency of onset of cry.Results:Of the 201 eligible participants,111 babies were excluded and remaining 90 babies were randomized into three groups of thirty each.The groups did not differ significantly in baseline characteristics.Median (interquartile range,IQR) of duration of cry was lesser [35.86 (21.07-107.75) seconds] in babies receiving EMLA cream with breast feeding (EB group) and in babies receiving vapocoolant spray with breast feeding (VB group) [32.58 (21.25-106.21) seconds] as compared to babies receiving only breast feeding (BO group) [67.5 (27.6-180) seconds] (P=-0.147).Difference in median (IQR) of latency of cry was not statistically significant.Modified Facial Coding Score and Neonatal Infant Pain Scale at 1 minute and 3 minutes was significantly lower in the EB and VB group,as compared to the BO group (P<0.05).Conclusions:Addition of topical EMLA application or vapocoolant spray to breastfeeding during wDPT vaccination does not reduce duration of cry in infants up to 3 months of age.However,they are able to show reduction in pain score and further studies are warranted to assess their efficacy as pain relief measures in infants and children. 展开更多
关键词 diptheria pertussis and TETANUS vaccine eutectic mixture of local ANESTHETICS Modified Facial Coding Score Neonatal Infant PAIN Scale
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部